BioCina acquires exclusive CDMO rights to CelluTx’s leading Minicircle DNA technology platform
Adelaide, Südaustralien (ots/PRNewswire) – BioCina Pty Ltd, a global contract biopharmaceutical development and manufacturing organization (CDMO), announced that it has acquired exclusive rights to use CelluTx’s recombination-based plasmid system (RBPS)…